NEW YORK (GenomeWeb) – Wafergen Biosystems today announced a collaboration with a unit of the University of Toronto for the use of the company's sample preparation technology for affordable and large-scale BRCA1 and BRCA2 screening. 

The agreement is with the Familial Breast Cancer Research Unit of the Women's College Research Institute at the University of Toronto for the use of Wafergen's Seq-Ready TE System. Steven Narod, director of the Familial Breast Cancer Research Unit and Mohammad Akbari, an assistant professor at the university, will lead the research. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.